For two months now, biotech companies have been talking about the eventual need for a coronavirus vaccine booster in at least some segments of the population.
Just this past weekend, the U.S. Food and Drug Administration recommended additional doses of the joint Pfizer Inc. (NYSE: PFE) and BioNTech SE ADR (NASDAQ: BNTX) vaccine and the Moderna Inc. (NASDAQ: MRNA) vaccine for some immunocompromised people.
Yesterday, sources inside the Biden administration told USA Today that the government is planning to recommend vaccine booster shots for all Americans....More>>>